Testing of novel health ingredients
Testing of novel health ingredients against multi-mucosal disturbance and stress-induced immune suppression under a practical repetitive stress challenge model
Project Summary
Project life: TBC
Anticipated Benefits
Securing the viability of strategies that bolster mucosal robustness and mitigate stress-related immunosuppression by preserving the stock robustness and in turn reducing the risk of spiralling interventions due to increased susceptibility to infections.
£124k
Total Value
45%
Industry Contribution
44%
SAIC Contribution
11%
Academia Contribution
Partners
- Lallemand UK Ltd (AquaPharm Biodiscovery Ltd)
- Institute of Aquaculture at the University of Stirling
- BioMar UK Ltd